{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:05:10Z","timestamp":1783112710475,"version":"3.54.6"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["H2017007"],"award-info":[{"award-number":["H2017007"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2016YFC1306700"],"award-info":[{"award-number":["2016YFC1306700"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Key Foundation of China","doi-asserted-by":"crossref","award":["81830040"],"award-info":[{"award-number":["81830040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Medical Outstanding Talent","award":["JCRCA2016006"],"award-info":[{"award-number":["JCRCA2016006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Variation in genes implicated in homocysteine and lipid metabolism systems may influence antidepressant response for patients with major depressive disorder (MDD). This study aimed to investigate whether association of polymorphisms on the\n                      <jats:italic>MTHFR<\/jats:italic>\n                      ,\n                      <jats:italic>ApoE<\/jats:italic>\n                      and\n                      <jats:italic>ApoA4<\/jats:italic>\n                      genes with the treatment response in MDD subjects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 281 Han Chinese MDD patients received a single antidepressant drug (SSRI or SNRI) for at least 6\u2009weeks, among whom 275 were followed up for 8\u2009weeks. Their response to 6\u2009weeks\u2019 treatment and remission to 8\u2009weeks\u2019 treatment with antidepressant drugs was determined by changes in the 17-item Hamilton Depression Rating Scale (HARS-17) score. Single SNP and haplotype associations with treatment response were analyzed by UNPHASED 3.0.13. Logistic regression analysis was used to explore the interactions between genotypes and gender or drug type on treatment outcome, only those SNPs that had interactional association with gender or drug type were subjected to further stratified analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total group, the haplotype (C-A) in\n                      <jats:italic>MTHFR<\/jats:italic>\n                      (rsl801133 and rs1801131) and the\n                      <jats:italic>ApoE<\/jats:italic>\n                      rs405509 AA genotype were significantly associated with better efficacy of antidepressants; In gender subgroups, only haplotype (C-A) in\n                      <jats:italic>MTHFR<\/jats:italic>\n                      (rsl801133 and rs1801131) was significantly associated with better efficacy of antidepressants in male subgroup; In drug type subgroup, the haplotype (C-A) in\n                      <jats:italic>MTHFR<\/jats:italic>\n                      (rsl801133 and rs1801131) and haplotype (G-C) in\n                      <jats:italic>ApoE<\/jats:italic>\n                      (rs7412 and rs405509) were associated with better efficacy of antidepressants in SNRI treated subgroup; The\n                      <jats:italic>ApoA4<\/jats:italic>\n                      rs5092 G allele and GG genotype were associated with worse efficacy of antidepressants in SNRI treated subgroup.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Genetic polymorphisms in homocysteine and lipid metabolism systems are associated with antidepressant response, particularly for the interactions of the certain genetic with gender or drug type.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-020-02798-4","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T09:07:05Z","timestamp":1597396025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response"],"prefix":"10.1186","volume":"20","author":[{"given":"Baoyu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5480-0888","authenticated-orcid":false,"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"2798_CR1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.psychres.2017.01.060","volume":"250","author":"CL Vandeleur","year":"2017","unstructured":"Vandeleur CL, Fassassi S, Castelao E, Glaus J, Strippoli MF, Lasserre AM, Rudaz D, Gebreab S, Pistis G, Aubry JM, et al. Prevalence and correlates of DSM-5 major depressive and related disorders in the community. Psychiatry Res. 2017;250:50\u20138.","journal-title":"Psychiatry Res"},{"issue":"3","key":"2798_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","volume":"6","author":"Y Huang","year":"2019","unstructured":"Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, Yu Y, Kou C, Xu X, Lu J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211\u201324.","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"2798_CR3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/da.22832","volume":"35","author":"ME Kelley","year":"2018","unstructured":"Kelley ME, Dunlop BW, Nemeroff CB, Lori A, Carrillo-Roa T, Binder EB, Kutner MH, Rivera VA, Craighead WE, Mayberg HS. Response rate profiles for major depressive disorder: characterizing early response and longitudinal nonresponse. Depress Anxiety. 2018;35(10):992\u20131000.","journal-title":"Depress Anxiety"},{"issue":"4","key":"2798_CR4","first-page":"241","volume":"27","author":"R Tranter","year":"2002","unstructured":"Tranter R, O'Donovan C, Chandarana P, Kennedy S. Prevalence and outcome of partial remissionin depression. J Psychiatry Neurosci. 2002;27(4):241\u20137.","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"2798_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14656560903508762","volume":"11","author":"FW Lohoff","year":"2010","unstructured":"Lohoff FW, Ferraro TN. Pharmacogenetic considerations in the treatment of psychiatric disorders. Expert Opin Pharmacother. 2010;11(3):423\u201339.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"2798_CR6","doi-asserted-by":"crossref","first-page":"e009510","DOI":"10.1136\/bmjopen-2015-009510","volume":"6","author":"RJ Mocking","year":"2016","unstructured":"Mocking RJ, Figueroa CA, Rive MM, Geugies H, Servaas MN, Assies J, Koeter MW, Vaz FM, Wichers M, van Straalen JP, et al. Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study. BMJ Open. 2016;6(3):e009510.","journal-title":"BMJ Open"},{"issue":"3","key":"2798_CR7","doi-asserted-by":"crossref","first-page":"e1074","DOI":"10.1038\/tp.2016.292","volume":"7","author":"TB Bigdeli","year":"2017","unstructured":"Bigdeli TB, Ripke S, Peterson RE, Trzaskowski M, Bacanu SA, Abdellaoui A, Andlauer TF, Beekman AT, Berger K, Blackwood DH, et al. Genetic effects influencing risk for major depressive disorder in China and Europe. Transl Psychiatry. 2017;7(3):e1074.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"2798_CR8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eat.22411","volume":"48","author":"E Vall","year":"2015","unstructured":"Vall E, Wade TD. Predictors of treatment outcome in individuals with eating disorders: a systematic review and meta-analysis. Int J Eating Disord. 2015;48(7):946\u201371.","journal-title":"Int J Eating Disord"},{"key":"2798_CR9","doi-asserted-by":"crossref","unstructured":"Fabbri C, Hosak L, M\u00f6ssner R, Giegling I, Mandelli L, Bellivier F, Claes S, Collier DA, Corrales A, Delisi LE, et al. Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response. World J Biol Psychiatry. 2017;18(1):5-28.","DOI":"10.1080\/15622975.2016.1208843"},{"issue":"5","key":"2798_CR10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/mp.2008.116","volume":"15","author":"M Kato","year":"2010","unstructured":"Kato M, Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry. 2010;15(5):473\u2013500.","journal-title":"Mol Psychiatry"},{"issue":"7\u20138","key":"2798_CR11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0899-9007(00)00327-0","volume":"16","author":"JE Alpert","year":"2000","unstructured":"Alpert JE, Mischoulon D, Nierenberg AA, Fava M. Nutrition and depression: focus on folate. Nutrition. 2000;16(7\u20138):544.","journal-title":"Nutrition"},{"issue":"12","key":"2798_CR12","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1176\/appi.ajp.159.12.2099","volume":"159","author":"H Tiemeier","year":"2002","unstructured":"Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: the Rotterdam study. Am J Psychiatr. 2002;159(12):2099.","journal-title":"Am J Psychiatr"},{"issue":"11","key":"2798_CR13","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.4088\/JCP.12020wc3","volume":"73","author":"R Jain","year":"2012","unstructured":"Jain R, Jackson WC. Beyond the resistance: how novel neurobiological understandings of depression may lead to advanced treatment strategies. J Clin Psychiatry. 2012;73(11):e30.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2798_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230209147396","volume":"14","author":"JE Alpert","year":"2002","unstructured":"Alpert JE, Mischoulon D, Rubenstein GEF, Bottonari K, Nierenberg AA, Fava M. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry. 2002;14(1):33\u20138.","journal-title":"Ann Clin Psychiatry"},{"key":"2798_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-244X-3-17","volume":"3","author":"J Hintikka","year":"2003","unstructured":"Hintikka J, Tolmunen T, Tanskanen A, Viinamaki H. High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry. 2003;3:17.","journal-title":"BMC Psychiatry"},{"issue":"22","key":"2798_CR16","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1093\/hmg\/ddi363","volume":"14","author":"P McGuffin","year":"2005","unstructured":"McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, Gill M, Korszun A, Maier W, Middleton L, et al. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet. 2005;14(22):3337\u201345.","journal-title":"Hum Mol Genet"},{"issue":"2B","key":"2798_CR17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1079\/PHN2001159","volume":"4","author":"C Cortese","year":"2001","unstructured":"Cortese C, Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr. 2001;4(2B):493\u20137.","journal-title":"Public Health Nutr"},{"issue":"1","key":"2798_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresrev.2009.08.003","volume":"62","author":"M Santos","year":"2009","unstructured":"Santos M, Kovari E, Hof PR, Gold G, Bouras C, Giannakopoulos P. The impact of vascular burden on late-life depression. Brain Res Rev. 2009;62(1):19\u201332.","journal-title":"Brain Res Rev"},{"issue":"1","key":"2798_CR19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41398-018-0276-6","volume":"8","author":"L Wan","year":"2018","unstructured":"Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R. Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry. 2018;8(1):242.","journal-title":"Transl Psychiatry"},{"key":"2798_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jad.2014.03.008","volume":"161","author":"X Shen","year":"2014","unstructured":"Shen X, Wu Y, Guan T, Wang X, Qian M, Lin M, Shen Z, Sun J, Zhong H, Yang J, et al. Association analysis of COMT\/MTHFR polymorphisms and major depressive disorder in Chinese Han population. J Affect Disord. 2014;161:73\u20138.","journal-title":"J Affect Disord"},{"issue":"9","key":"2798_CR21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/gps.3899","volume":"28","author":"BD Jamerson","year":"2013","unstructured":"Jamerson BD, Payne ME, Garrett ME, Ashley-Koch AE, Speer MC, Steffens DC. Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression. Int J Geriatr Psychiatry. 2013;28(9):925\u201332.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7\u20138","key":"2798_CR22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3109\/02699051003789229","volume":"24","author":"KL Lanct\u00f4t","year":"2010","unstructured":"Lanct\u00f4t KL, Rapoport MJ, Chan F, Rajaram RD, Strauss J, Sicard T, McCullagh S, Feinstein A, Kiss A, Kennedy JL, et al. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. Brain Inj. 2010;24(7\u20138):959\u201369.","journal-title":"Brain Inj"},{"issue":"7","key":"2798_CR23","first-page":"888","volume":"68","author":"F Mei","year":"2018","unstructured":"Mei F, Wu Y, Ding G, Pan F, Chen L, Wu J. Association of methylenetetrahydrofolate reductase gene 677C>T polymorphism with post-stroke depression risk and antidepressant treatment response in Han Chinese. JPMA. 2018;68(7):888\u201392.","journal-title":"JPMA"},{"issue":"2","key":"2798_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1017\/S1092852912000430","volume":"17","author":"D Mischoulon","year":"2012","unstructured":"Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, et al. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. CNS Spectrums. 2012;17(2):76\u201386.","journal-title":"CNS Spectrums"},{"issue":"3","key":"2798_CR25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0447.1997.tb09622.x","volume":"95","author":"M Maes","year":"1997","unstructured":"Maes M, Smith R, Christophe A, Vandoolaeghe E, Gastel AV, Neels H, Demedts P, Wauters A, Meltzer HY. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand. 1997;95(3):212.","journal-title":"Acta Psychiatr Scand"},{"key":"2798_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-981-32-9721-0_3","volume":"1192","author":"M Nikolac Perkovic","year":"2019","unstructured":"Nikolac Perkovic M, Pivac N. Genetic markers of Alzheimer's disease. Adv Exp Med Biol. 2019;1192:27\u201352.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"2798_CR27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2174\/1389450119666180406112050","volume":"19","author":"W Chen","year":"2018","unstructured":"Chen W, Jin F, Cao G, Mei R, Wang Y, Long P, Wang X, Ge W. ApoE4 may be a promising target for treatment of coronary heart disease and Alzheimer's disease. Curr Drug Targets. 2018;19(9):1038\u201344.","journal-title":"Curr Drug Targets"},{"issue":"15","key":"2798_CR28","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A. 2006;103(15):5644\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2798_CR29","doi-asserted-by":"crossref","unstructured":"F.Sharpley C: The role of genes (and environmental stress) in depression: an update. Curr Psychiatr Rev 2011, 7(2):84\u201395.","DOI":"10.2174\/157340011796391175"},{"issue":"3","key":"2798_CR30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/ijmm.2013.1250","volume":"31","author":"YS Kim","year":"2013","unstructured":"Kim YS, Gu BH, Choi BC, Kim MS, Song S, Yun JH, Chung MK, Choi CH, Baek KH. Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome. Int J Mol Med. 2013;31(3):707\u201316.","journal-title":"Int J Mol Med"},{"key":"2798_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2016.07.006","volume":"82","author":"BS Diniz","year":"2016","unstructured":"Diniz BS, Lin CW, Sibille E, Tseng G, Lotrich F, Aizenstein HJ, Reynolds CF, Butters MA. Circulating biosignatures of late-life depression (LLD): towards a comprehensive, data-driven approach to understanding LLD pathophysiology. J Psychiatr Res. 2016;82:1\u20137.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"2798_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-6147(00)01603-5","volume":"22","author":"D Pickar","year":"2001","unstructured":"Pickar D, Rubinow K. Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci. 2001;22(2):75\u201383.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"2798_CR33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0269881111414452","volume":"26","author":"Z Xu","year":"2012","unstructured":"Xu Z, Zhang Z, Shi Y, Pu M, Yuan Y, Zhang X, Li L, Reynolds GP. Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. J Psychopharmacol. 2012;26(3):349\u201359.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"2798_CR34","first-page":"97","volume":"11","author":"Association AP","year":"1994","unstructured":"Association AP. Diagnostic and statistic manual of mental disorders 5 (DSM-5). Diabetes. 1994;11(1):97\u20138.","journal-title":"Diabetes"},{"issue":"8","key":"2798_CR35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.ejcn.1602804","volume":"62","author":"MH Kamphuis","year":"2008","unstructured":"Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D. Dietary intake of B (6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen elderly study. Eur J Clin Nutr. 2008;62(8):939\u201345.","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"2798_CR36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.pnpbp.2005.06.021","volume":"29","author":"T Bottiglieri","year":"2005","unstructured":"Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2005;29(7):1103\u201312.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"12","key":"2798_CR37","first-page":"1614","volume":"45","author":"W Herrmann","year":"2007","unstructured":"Herrmann W, Obeid R. Biomarkers of folate and vitamin B (12) status in cerebrospinal fluid. Clin Chem Lab Med. 2007;45(12):1614\u201320.","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"2798_CR38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/ajp.145.9.1110","volume":"145","author":"KM Bell","year":"1988","unstructured":"Bell KM, Plon L, Bunney WE Jr, Potkin SG. S-adenosylmethionine treatment of depression: a controlled clinical trial. Am J Psychiatry. 1988;145(9):1110\u20134.","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"2798_CR39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2010.07.029","volume":"130","author":"H Christensen","year":"2011","unstructured":"Christensen H, Aiken A, Batterham PJ, Walker J, Mackinnon AJ, Fenech M, Hickie IB. No clear potentiation of antidepressant medication effects by folic acid+vitamin B12 in a large community sample. J Affect Disord. 2011;130(1\u20132):37\u201345.","journal-title":"J Affect Disord"},{"issue":"3","key":"2798_CR40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ejcn.2009.143","volume":"64","author":"A Nanri","year":"2010","unstructured":"Nanri A, Mizoue T, Matsushita Y, Sasaki S, Ohta M, Sato M, Mishima N. Serum folate and homocysteine and depressive symptoms among Japanese men and women. Eur J Clin Nutr. 2010;64(3):289\u201396.","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"2798_CR41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11883-004-0097-3","volume":"6","author":"DK Kalra","year":"2004","unstructured":"Kalra DK. Homocysteine and cardiovascular disease. Curr Atheroscler Rep. 2004;6(2):101\u20136.","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"2798_CR42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.69.2.228","volume":"69","author":"T Bottiglieri","year":"2000","unstructured":"Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 2000;69(2):228\u201332.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"2798_CR43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.30773\/pi.2019.03.24","volume":"16","author":"EJ Kim","year":"2019","unstructured":"Kim EJ, Hong J, Hwang J-W. The association between depressive mood and cholesterol levels in Korean adolescents. Psychiatry Investig. 2019;16(10):737\u201344.","journal-title":"Psychiatry Investig"},{"issue":"4","key":"2798_CR44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1176\/appi.psy.43.4.310","volume":"43","author":"SB Sonawalla","year":"2002","unstructured":"Sonawalla SB, Papakostas GI, Petersen TJ, Yeung AS, Smith MM, Sickinger AH, Gordon J, Israel JA, Tedlow JR, Lamon-Fava S, et al. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder. Psychosomatics. 2002;43(4):310\u20136.","journal-title":"Psychosomatics"},{"issue":"1","key":"2798_CR45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbamem.2005.06.005","volume":"1714","author":"TJ Pucadyil","year":"2005","unstructured":"Pucadyil TJ, Chattopadhyay A. Cholesterol modulates the antagonist-binding function of hippocampal serotonin1A receptors. Biochim Biophys Acta Biomembr. 2005;1714(1):35\u201342.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"5","key":"2798_CR46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/fampra\/cmx052","volume":"34","author":"M Su\u00e1rez Bagnasco","year":"2017","unstructured":"Su\u00e1rez Bagnasco M. Psychological issues and cognitive impairment in adults with familial hypercholesterolemia. Fam Pract. 2017;34(5):520\u20134.","journal-title":"Fam Pract"},{"issue":"4","key":"2798_CR47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0193-953X(05)70197-0","volume":"23","author":"D Mischoulon","year":"2000","unstructured":"Mischoulon D, Fava M. Docosahexanoic acid and omega-3 fatty acids in depression. Psychiatric Clin North Am. 2000;23(4):785\u201394.","journal-title":"Psychiatric Clin North Am"},{"issue":"7","key":"2798_CR48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0006-3223(03)00174-4","volume":"54","author":"GM Murphy","year":"2003","unstructured":"Murphy GM, Kremer C, Rodrigues H, Schatzberg AF. The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients. Biol Psychiatry. 2003;54(7):665\u201373.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2798_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s001270050017","volume":"33","author":"B Schmand","year":"1998","unstructured":"Schmand B, Hooijer C, Jonker C, Lindeboom J, Havekes LM. Apolipoprotein E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Psychiatr Epidemiol. 1998;33(1):21\u20136.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"3","key":"2798_CR50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00019442-200008000-00003","volume":"8","author":"M Mauricio","year":"2000","unstructured":"Mauricio M, O'Hara R, Yesavage JA, Friedman L, Kraemer HC, Van De Water M, Murphy GM Jr. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. Am J Geriatr Psychiatry. 2000;8(3):196\u2013200.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"2798_CR51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/ejhg.2008.263","volume":"17","author":"A Bizzarro","year":"2009","unstructured":"Bizzarro A, Seripa D, Acciarri A, Matera MG, Pilotto A, Tiziano FD, Brahe C, Masullo C. The complex interaction between APOE promoter and AD: an Italian case-control study. Eur J Hum Genet. 2009;17(7):938\u201345.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2798_CR52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JAD-2011-101764","volume":"24","author":"F Lescai","year":"2011","unstructured":"Lescai F, Chiamenti AM, Codemo A, Pirazzini C, D'Agostino G, Ruaro C, Ghidoni R, Benussi L, Galimberti D, Esposito F, et al. An APOE haplotype associated with decreased epsilon4 expression increases the risk of late onset Alzheimer's disease. J Alzheimer\u2019s Dis. 2011;24(2):235\u201345.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"2798_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00539-1","volume":"157","author":"M Groenendijk","year":"2001","unstructured":"Groenendijk M, Cantor RM, de Bruin TW, Dallinga-Thie GM. The apoAI-CIII-AIV gene cluster. Atherosclerosis. 2001;157(1):1\u201311.","journal-title":"Atherosclerosis"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02798-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-020-02798-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02798-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T18:17:24Z","timestamp":1667758644000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-020-02798-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2798"],"URL":"https:\/\/doi.org\/10.1186\/s12888-020-02798-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20389\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20389\/v2","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors state that the study was established according to the ethical guidelines of the Helsinki Declaration and was approved by the ethics committee of ZhongDa Hospital affiliated to Southeast University or other hospitals participating in the study. Written informed consent was obtained from all subjects or guardian participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that Yonggui Yuan as a member of Editorial Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"408"}}